New morpholine-containing pyrimidinones act on α-adrenoceptors (2024)
- Authors:
- USP affiliated authors: PASSAGLIA, RITA DE CASSIA ALEIXO TOSTES - FMRP ; RODRIGUES, DANIEL - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ejphar.2024.176788
- Subjects: ANTAGONISMO DE DROGAS; AGENTES DOPAMINÉRGICOS; ADRENORECEPTORES; COMPOSTOS HETEROCÍCLICOS
- Keywords: Antagonism; Agonism; Adrenoceptors
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Pharmacology
- ISSN: 0014-2999
- Volume/Número/Paginação/Ano: v. 978, n. 5, art. 176788, [14] p., 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ALVES, Silvia Maria de Luna et al. New morpholine-containing pyrimidinones act on α-adrenoceptors. European Journal of Pharmacology, v. 978, n. 5, p. [14] , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2024.176788. Acesso em: 27 jan. 2026. -
APA
Alves, S. M. de L., Silva, S. B. da, Santos, R. C. A., Feitosa, S. G., Farias, P. H. M. de, Silva-Júnior, J. A., et al. (2024). New morpholine-containing pyrimidinones act on α-adrenoceptors. European Journal of Pharmacology, 978( 5), [14] . doi:10.1016/j.ejphar.2024.176788 -
NLM
Alves SM de L, Silva SB da, Santos RCA, Feitosa SG, Farias PHM de, Silva-Júnior JA, Rodrigues D, Potje SR, Tostes R de CA, Anjos JV dos, Araújo AV. New morpholine-containing pyrimidinones act on α-adrenoceptors [Internet]. European Journal of Pharmacology. 2024 ; 978( 5): [14] .[citado 2026 jan. 27 ] Available from: https://doi.org/10.1016/j.ejphar.2024.176788 -
Vancouver
Alves SM de L, Silva SB da, Santos RCA, Feitosa SG, Farias PHM de, Silva-Júnior JA, Rodrigues D, Potje SR, Tostes R de CA, Anjos JV dos, Araújo AV. New morpholine-containing pyrimidinones act on α-adrenoceptors [Internet]. European Journal of Pharmacology. 2024 ; 978( 5): [14] .[citado 2026 jan. 27 ] Available from: https://doi.org/10.1016/j.ejphar.2024.176788 - Aldosterona via receptor mineralocorticoide reduz a atividade de Nrf2 e promove disfunção vascular
- Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases
- Pharmacological activation of nuclear factor erythroid 2-related factor-2 prevents hyperglycemia-induced renal oxidative damage: possible involvement of O-GlcNAcylation
- Perivascular adipose tissue as a relevant fat depot for cardiovascular risk in obesity
- Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats
- Upregulation of c-Src-dependent non-genomic signaling by aldosterone in vascular smooth muscle cells from spontaneously hypertensive rats
- Impaired β-adrenoceptor-induced relaxation in small mesenteric arteries from DOCA-salt hypertensive rats is due to reduced Kca channel activity
- Augmented vascular reactivity induced by ET-1 is associated with increased O-GlcNAcylation
- Decreased diacylglycerol kinase contributes to enhanced vascular contraction in aorta from angiotensin II hypertensive mice
- DOCA-salt hypertensive rats display decreased vascular reactivity to urotensin-II
Informações sobre o DOI: 10.1016/j.ejphar.2024.176788 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
